Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat

Nephrology Dialysis Transplantation

Volumn 18, Issue 3, 2003, Pages 491-496

  Nielsen, Finn Thomsen ^a   Ottosen, Peter ^a   Starklint, Henrik ^a   Dieperink, Hans ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cyclosporine A; Immunosuppression; Nephrotoxicity; Renal morphology; Sirolimus; Tacrolimus

Indexed keywords

CALCINEURIN INHIBITOR; COBALT EDETATE; CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG POTENTIATION; DRUG TOLERABILITY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SCORING SYSTEM; SHORT COURSE THERAPY; STEREOMETRY;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIROLIMUS; TACROLIMUS; TIME FACTORS;

EID: 0037341439     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.3.491     Document Type: Article

References (20)

1. DiJoseph JF, Sharma RN, Chang JY. The effect of rapamycin on the kidney function in the Sprague-Dawley rat. Transplantation 1992; 53: 507-513
2. Sindhi R, Webber S, Venkataramanan R et al. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001; 72: 851-855
3. Kreis H, Cisterne JM, Land W et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; 69: 1252-1260
4. MacDonald AS. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271-280
5. Ferron GM, Mishina EV, Zimmerman JJ, Jusko WJ. Population pharmacokinetics of sirolimus in kidney transplant patients. Clin Pharmacol Ther 1997; 61: 416-428
6. Thliveris JA, Yatscoff RW. Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit. Transplantation 1995; 59: 427-429
7. Qi S, Xu D, Peng J et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. Transplantation 2000; 69: 1275-1283
8. Golbækdal K, Nielsen CB, Djurhuus JC, Pedersen EB. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs. Transplantation 1994; 58: 1153-1157
9. Wang W, Chan YH, Lee W, Chan L. Effect of rapamycin and FK506 on mesangial cell proliferation. Transplant Proc 2001; 33: 1036-1037
10. Dieperink H, Leyssac PP, Starklint H, Kemp E. Long-term cyclosporin nephrotoxicity in the rat: effects on renal function and morphology. Nephrol Dial Transplant 1988; 3: 317-326
11. Nielsen FT, Leyssac PP, Kemp E, Starklint H, Dieperink H. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity. Nephrol Dial Transplant 1995; 10: 334-340
12. Ochiai T, Gunji Y, Nagata M, Komori A, Asano T, Isono K. Effects of rapamycin in experimental organ allografting. Transplantation 1993; 56: 15-19
13. Stepkowski SM, Tian L, Napoli KL et al. Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection. Clin Exp Immunol 1997; 108: 63-68
14. Vu MD, Qi S, Xu D et al. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. Transplantation 1997; 64: 1853-1856
15. Fealy MJ, Umansky WS, Bickel KD, Nino JJ, Morris RE, Press BH. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival. Ann Surg 1994; 219: 88-93
16. Chen H, Qi S, Xu D et al. FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse. Transplant Proc 1998; 30: 1039-1041
17. Kaplan B, Meier-Krische HU, Napoli KL, Kahan BD. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin Pharmacol Ther 1998; 63: 48-53
18. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 2000; 356: 194-202
19. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996; 50: 1110-1117
20. Salazar A, McAlister VC, Kiberd BA, Bitter-Suermann H, Al-Kerithy MF, MacDonald AS. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function. Transplant Proc 2001; 33: 1038-1039